npj Schizophrenia (Sep 2021)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis

  • Maria Lee,
  • Helena Fatouros-Bergman,
  • Pontus Plavén-Sigray,
  • Pauliina Ikonen Victorsson,
  • Carl M. Sellgren,
  • Sophie Erhardt,
  • Lena Flyckt,
  • Lars Farde,
  • Simon Cervenka

DOI
https://doi.org/10.1038/s41537-021-00176-x
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Cognitive impairment is an important predictor of disability in schizophrenia. Dopamine neurotransmission in cortical brain regions has been suggested to be of importance for higher-order cognitive processes. The aim of this study was to examine the relationship between extrastriatal dopamine D2-R availability and cognitive function, using positron emission tomography and the high-affinity D2-R radioligand [11C]FLB 457, in an antipsychotic-naive sample of 18 first-episode psychosis patients and 16 control subjects. We observed no significant associations between D2-R binding in the dorsolateral prefrontal cortex or hippocampus (β = 0.013–0.074, partial r = −0.037–0.273, p = 0.131–0.841). Instead, using Bayesian statistics, we found moderate support for the null hypothesis of no relationship (BFH0:H1 = 3.3–8.2). Theoretically, our findings may suggest a lack of detrimental effects of D2-R antagonist drugs on cognition in schizophrenia patients, in line with clinical observations.